Browse result page of THPdb

The total number entries retrieved from this search are 13

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1422	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandPancrecarb	CompanyDigestive care US, Inc.	Physical AppearanceDelayed-Release Capsules, Buffered and Enteric-Coated Microspheres.	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1423	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandViokace	CompanyAptalis Pharma US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble in alcohol and converted to tablet form	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1424	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandULTRESA	CompanyAptalis Pharma US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether and converted to Delayed-Release Capsules	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1425	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandPERTZYE	CompanyDigestive care US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether PERTZYE delayed-release capsule	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1426	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandULTRASE	CompanyAxcan Pharma	Physical AppearanceCapsules Enteric-Coated Microspheres	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1427	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandZENPEP	CompanyAptalis Pharma US, Inc.	Physical AppearanceDelayed-Release Capsules	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1648	ThPPIDTh1148	NameAliskiren	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseMetabolic	BrandTekturna	CompanyPhysicians Total Care, Inc.	Physical AppearanceLight-pink, biconvex round tablet	Route of AdministartionOral route	CategoryRenin inhibitor	TargetRenin
ID1649	ThPPIDTh1148	NameAliskiren	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseMetabolic	BrandTekturna	CompanyNovartis Pharmaceuticals Corporation	Physical AppearanceLight-pink, biconvex round tablet	Route of AdministartionOral route	CategoryRenin inhibitor	TargetRenin
ID1650	ThPPIDTh1148	NameAliskiren	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseMetabolic	BrandTekturna HCT	CompanyNovartis Pharmaceuticals Corporation	Physical AppearanceBiconvex, ovaloid film-coated tablets.	Route of AdministartionOral route	CategoryRenin inhibitor	TargetRenin
ID1651	ThPPIDTh1148	NameAliskiren	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseMetabolic	BrandTekamlo	CompanyNovartis Pharmaceuticals Corporation	Physical AppearanceTablets (aliskiren/amlodipine): 150 mg/5 mg, 150 mg/10 mg, 300 mg/5 mg, 300 mg/10 mg	Route of AdministartionOral route	CategoryRenin inhibitor	TargetRenin
ID1652	ThPPIDTh1148	NameAliskiren	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseMetabolic	BrandAmturnide	CompanyNovartis Pharmaceuticals Corporation	Physical AppearanceTablets (aliskiren/ amlodipine/ HCTZ): 150/5/12.5, 300/5/12.5, 300/5/25, 300/10/12.5, 300/10/25 mg.ÂÂÂ	Route of AdministartionOral route	CategoryRenin inhibitor	TargetRenin
ID1653	ThPPIDTh1149	NameRagweed Pollen Extract	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIIa	DiseaseImmunological	BrandRagwitek	CompanyMerck Sharp & Dohme	Physical AppearanceTablets	Route of AdministartionOral route	CategoryN.A.	TargetN.A.
ID1804	ThPPIDTh1198	NameSacrosidase	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseGenetic Disorders	BrandSucraid	CompanyQOL Medical, LLC	Physical AppearanceSolution	Route of AdministartionOral	CategoryEnzymes	TargetNA